Department of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Post-baccalaureate Research Education Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL, 32224, USA.
Mol Neurodegener. 2023 Aug 14;18(1):55. doi: 10.1186/s13024-023-00645-0.
Alzheimer's disease (AD) is an aging-related form of dementia associated with the accumulation of pathological aggregates of amyloid beta and neurofibrillary tangles in the brain. These phenomena are accompanied by exacerbated inflammation and marked neuronal loss, which altogether contribute to accelerated cognitive decline. The multifactorial nature of AD, allied to our still limited knowledge of its etiology and pathophysiology, have lessened our capacity to develop effective treatments for AD patients. Over the last few decades, genome wide association studies and biomarker development, alongside mechanistic experiments involving animal models, have identified different immune components that play key roles in the modulation of brain pathology in AD, affecting its progression and severity. As we will relay in this review, much of the recent efforts have been directed to better understanding the role of brain innate immunity, and particularly of microglia. However, and despite the lack of diversity within brain resident immune cells, the brain border tissues, especially the meninges, harbour a considerable number of different types and subtypes of adaptive and innate immune cells. Alongside microglia, which have taken the centre stage as important players in AD research, there is new and exciting evidence pointing to adaptive immune cells, namely T and B cells found in the brain and its meninges, as important modulators of neuroinflammation and neuronal (dys)function in AD. Importantly, a genuine and functional lymphatic vascular network is present around the brain in the outermost meningeal layer, the dura. The meningeal lymphatics are directly connected to the peripheral lymphatic system in different mammalian species, including humans, and play a crucial role in preserving a "healthy" immune surveillance of the CNS, by shaping immune responses, not only locally at the meninges, but also at the level of the brain tissue. In this review, we will provide a comprehensive view on our current knowledge about the meningeal lymphatic vasculature, emphasizing its described roles in modulating CNS fluid and macromolecule drainage, meningeal and brain immunity, as well as glial and neuronal function in aging and in AD.
阿尔茨海默病(AD)是一种与大脑中淀粉样β蛋白和神经原纤维缠结的病理性聚集相关的与衰老有关的痴呆形式。这些现象伴随着炎症加剧和明显的神经元丧失,这共同导致认知能力加速下降。AD 的多因素性质,以及我们对其病因和病理生理学的认识仍然有限,降低了我们为 AD 患者开发有效治疗方法的能力。在过去几十年中,全基因组关联研究和生物标志物的开发,以及涉及动物模型的机制实验,已经确定了不同的免疫成分在 AD 大脑病理的调节中发挥关键作用,影响其进展和严重程度。正如我们将在这篇综述中传达的那样,最近的大部分努力都致力于更好地理解大脑固有免疫的作用,特别是小胶质细胞。然而,尽管大脑常驻免疫细胞的多样性有限,但大脑边界组织,特别是脑膜,含有大量不同类型和亚型的适应性和固有免疫细胞。除了作为 AD 研究中重要角色的小胶质细胞外,还有新的令人兴奋的证据表明适应性免疫细胞,即大脑和脑膜中的 T 和 B 细胞,是 AD 中神经炎症和神经元(功能)障碍的重要调节剂。重要的是,在大脑最外层脑膜的脑膜周围存在真正和功能性的淋巴管网络。脑膜淋巴管在不同的哺乳动物物种中与外周淋巴系统直接相连,并通过塑造免疫反应,不仅在脑膜局部,而且在脑组织水平,在维持中枢神经系统的“健康”免疫监视方面发挥关键作用。在这篇综述中,我们将提供对脑膜淋巴管血管系统的全面了解,强调其在调节中枢神经系统液体和大分子引流、脑膜和大脑免疫以及衰老和 AD 中神经胶质和神经元功能方面的描述作用。